comprehensive -WSS

comprehensive

author：fashion 2025-09-27 16:49:06 - browse：192

Americans who suffer severe allergic reactions won’t have alternatives to auto-injectors like the EpiPen for a while longer. In a surprise move, the Food and Drug Administration on Tuesday declined to approve neffy, an epinephrine nasal spray. Instead, the FDA asked the drug’s manufacturer, ARS Pharma, to conduct further studies, specifically comparing the effect of repeat doses of epinephrine administered via nasal spray versus auto-injection in people with allergic rhinitis, or hay fever.

This was unexpected, and disappointing, for ARS Pharma: In May, an FDA advisory committee had voted 16-6 in favor of neffy’s approval for adults, and 17-5 in favor for children. But there is at least one party that’s likely to benefit from this development: Viatris, the maker of EpiPen, the brand-name epinephrine auto-injector used to treat anaphylaxis. (A generic version is also available, made by Teva).

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Sutter Health’s antitrust win overturned by appeals court

leisure time

WSS

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Eli Lilly’s Zepbound improved liver scarring in mid

Data don't support strong claims for Covid

STAT wants to know your pick for a great summer read or listen

How to ethically and practically extend health care to all

Alnylam reports growth in sales of rare disease treatments

Wikipedia

comprehensive

explore

23andMe had bad news about my health. I wish a person had delivered it

Elevance PBM president out as customers face prescription chaos

Wildfire smoke exposes gaps in outdoor worker protections

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Hollywood unions extend contract negotiations for actors

2 officers injured in shooting in Orlando, police say

Dobbs anniversary: the lost opportunity of abortion as health care

An outdated Medicare rule harms dementia patients with anxiety

Duchenne breakthrough therapy leaves behind pioneering families

How CO2 helps viruses stay alive longer in the air

knowledge

How I helped Pfizer think through the ethics of Viagra

How CO2 helps viruses stay alive longer in the air

A controversial new treatment promises to make little people taller

Biotech startup Celsius cuts 75% of staff ahead of first trial start

How to ethically and practically extend health care to all

For pregnant people, addiction treatment shouldn't mean a call to child protective services

focus

hotspot

leisure time

entertainment